华熙生物：预计2025年净利润同比增加54.93%到83.63%

Core Viewpoint - The company Huaxi Biological announced an expected net profit attributable to the parent company of RMB 270 million to 320 million for the year 2025, indicating a significant increase compared to the previous year [1] Financial Performance - The projected net profit represents an increase of RMB 95.73 million to RMB 145.73 million compared to the previous year's net profit of RMB 174.27 million, reflecting a year-on-year growth of 54.93% to 83.63% [1] - The net profit attributable to the parent company, excluding non-recurring gains and losses, was RMB 107.27 million in the previous year, which contributes to the substantial variation in the company's performance [1]